Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares U.S. Pharmaceutical ETF (NY:IHE)

105.89 -1.52 (-1.42%)
Streaming Delayed Price Updated: 9:51 AM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,471
Open 107.24
Bid (Size) 105.97 (1,000)
Ask (Size) 106.09 (200)
Prev. Close 107.41
Today's Range 105.89 - 107.24
52wk Range 69.02 - 108.66
Shares Outstanding 82,000
Dividend Yield 1.08%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? ↗
IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk. 
Via The Motley Fool
Topics ETFs
News headline image
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech? ↗
VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+24.8%
+24.8%
1 Month
+2.9%
+2.9%
3 Month
+16.1%
+16.1%
6 Month
+15.6%
+15.6%
1 Year
+51.2%
+51.2%

More News

Read More
News headline image
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? ↗
Via The Motley Fool
Topics ETFs
KZIA Stock Is Rising Today — What Does Its Data For Nuclear PD-L1 Degrader Show? ↗
Via Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
Via Stocktwits
News headline image
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins? ↗
Via The Motley Fool
Topics ETFs
News headline image
XLV vs. IHE: Which Healthcare ETF Is the Better Buy? ↗
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF? ↗
Via The Motley Fool
Topics ETFs
News headline image
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now? ↗
Via The Motley Fool
Topics ETFs
News headline image
IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors? ↗
Via The Motley Fool
Topics ETFs
News headline image
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH? ↗
Via The Motley Fool
Topics ETFs
News headline image
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? ↗
Via The Motley Fool
Topics ETFs
News headline image
IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors? ↗
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? ↗
Via The Motley Fool
Topics ETFs
News headline image
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns ↗
Via The Motley Fool
Topics ETFs
News headline image
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. ↗
Via The Motley Fool
Topics ETFs
News headline image
FDA Vaccine Chief Vinay Prasad To Exit Agency In April: Report ↗
Via Stocktwits
News headline image
TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗
Via Stocktwits
Topics Workforce
News headline image
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development ↗
Via Stocktwits
Topics ETFs Government
News headline image
Why Did IINN Stock Surge 28% In Pre-Market Today? ↗
Via Stocktwits
News headline image
HIMS New $49 Pill Lifts Stock 10%, But Why Are NVO, LLY Stocks Falling? ↗
Via Stocktwits
Topics Intellectual Property
News headline image
LLY Stock Surges Pre-Market: Obesity, Diabetes Drugs Drive Strong FY26 Outlook ↗
Via Stocktwits
News headline image
US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗
Via Stocktwits
Topics World Trade
News headline image
Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗
Via Benzinga
Topics ETFs
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
Via Benzinga

Frequently Asked Questions

Is iShares U.S. Pharmaceutical ETF publicly traded?
Yes, iShares U.S. Pharmaceutical ETF is publicly traded.
What exchange does iShares U.S. Pharmaceutical ETF trade on?
iShares U.S. Pharmaceutical ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares U.S. Pharmaceutical ETF?
The ticker symbol for iShares U.S. Pharmaceutical ETF is IHE on the New York Stock Exchange
What is the current price of iShares U.S. Pharmaceutical ETF?
The current price of iShares U.S. Pharmaceutical ETF is 105.89
When was iShares U.S. Pharmaceutical ETF last traded?
The last trade of iShares U.S. Pharmaceutical ETF was at 08/26/26 09:51 AM ET
What is the market capitalization of iShares U.S. Pharmaceutical ETF?
The market capitalization of iShares U.S. Pharmaceutical ETF is 8.68M
How many shares of iShares U.S. Pharmaceutical ETF are outstanding?
iShares U.S. Pharmaceutical ETF has 9M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.